Mantovani, L. et al. 2024. Cost-Effectiveness of Dimethyl Fumarate Compared to Teriflunomide for Relapsing Remitting Multiple Sclerosis Patients in Italy: Results of an Updated Analysis. Farmeconomia. Health economics and therapeutic pathways. 25, 1 (Dec. 2024). DOI:https://doi.org/10.7175/fe.v25i1.1568.